Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Figure 1

Kaplan-Meier plots of TTP and OS, according to 6-bp deletion polymorphism in 3'UTR of TS. The 6-bp deletion homozygote (-6 bp/-6 bp) was significantly associated with prolonged TTP (6.3 months vs. 4.7 months in +6 bp/+6 bp or +6 bp/-6 bp, p = 0.014) and OS (17.8 months vs. 10.3 months in +6 bp/+6 bp or +6 bp/-6 bp, p = 0.032).

Back to article page
\